Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Pad. Marcora

Milan 20122

0 studies enrolling now · 2 studies all time

What they study most

Depressive Disorder, Major, Myelodysplastic Syndromes

Studies at this site

• A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI) — Completed
• Study to Separately Evaluate the Activity of Talacotuzumab (JNJ-56022473) or Daratumumab in Transfusion-Dependent Participants With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) Who Are Relapsed or Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment — Completed